Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01536912 · ClinicalTrials.gov registry record
Medical Marijuana Use in HIV+ Patients: Probability Survey
A clinical trial of HIV Positive, sponsored by Wayne State University.
- Completed
- Registry status
- 218
- Enrollment target
- 1
- Study location
NCT01536912: Completed study of HIV Positive, sponsored by Wayne State University.
NCT01536912 is a study of HIV Positive that has completed, run by Wayne State University. The registered enrollment target is 218 participants, below the 603-participant average among 3 other HIV Positive trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01536912, a study of HIV Positive, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 218 participants
- Enrollment target
- 1
- Study location
Study Summary
More scientific information is needed about medical marijuana use among HIV positive patients. There is conflicting information about the use of marijuana, use of medical marijuana, and the associations between them and health status/health risk behaviors/health care utilization. In addition, it is not clear whether patients who participate in prospective clinical studies differ from participants who do not participate; if there are differences between those two groups, then this would limit generalizability of knowledge about these issues. The goal of this project is to describe the use of marijuana among HIV positive patients and its association with health status/health risk behaviors/health care utilization.
Conditions Studied
Study Locations (1)
Michigan
- Wayne State University (HIV clinic, Tolan Park Medical Building) - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2012-02 |
| Est. Completion | 2014-12 |
What the finished NCT01536912 record still lists
NCT01536912 is an observational study that tracks outcomes without assigning an intervention. The registered 218 participants enrollment target is mid-sized for trials with a published cap, below the 603-participant average among 3 other HIV Positive trials with a reported enrollment target (64% lower).
The record links to 1 condition, with HIV Positive appearing as the primary indexed condition, and to 0 interventions.
NCT01536912 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT01536912 about?
NCT01536912 is a clinical study titled "Medical Marijuana Use in HIV+ Patients: Probability Survey". More scientific information is needed about medical marijuana use among HIV positive patients. There is conflicting information about the use of marijuana, use of medical marijuana, and the associations between them and health status/health risk behaviors/health care utilization. In addition, it is ...
What is the current status of trial NCT01536912?
This trial is currently completed. The enrollment target is 218 participants. The study started on 2012-02. Estimated completion is 2014-12.
What conditions does trial NCT01536912 study?
This clinical trial studies the following conditions: HIV Positive.
Who is sponsoring clinical trial NCT01536912?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01536912 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Positive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04693858 · 218 participants · NA
Efficacy Trial of the CALM Intervention
- NCT05909202 · 218 participants · NA
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
- NCT06000761 · 218 participants · NA
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
- NCT06249126 · 218 participants · NA
Primary Subtalar Arthrodesis for Calcaneal Fractures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia